Stock In Focus – TAM Stock Screener – AbbVie Inc (ABBV)

Johnny HopkinsStock ScreenerLeave a Comment

As part of our ongoing series here at The Acquirer’s Multiple, we provide this feature article titled ‘Stock in Focus‘ where we focus on one of the stocks from our Stock Screeners.

One of the cheapest stocks in our Stock Screeners is:

AbbVie Inc (ABBV)

AbbVie is a pharmaceutical firm with a strong exposure to immunology and oncology. The firm’s top drug, Humira, represents close to half of the company’s current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women’s health.

A quick look at the share price history (below) over the past twelve months shows that the price is down 5.51%. Here’s why the company is undervalued.

ABBV Chart

ABBV data by YCharts

Key Stats

Market Cap: $250.31 Billion

Enterprise Value: $305.71 Billion

Operating Earnings

Operating Earnings: $23.30 Billion

Acquirer’s Multiple

Acquirer’s Multiple: 13.10

Free Cash Flow (TTM)

Free Cash Flow: $23.52 Billion

FCF/EV Yield %:

FCF/EV Yield: 9.40

Shareholder Yield %:

Shareholder Yield: 4.80

Other Indicators

Piotroski F-Score: 5.00

Altman Z-Score: 2.104

ROA (5 Year Avge%): 17

For all the latest news and podcasts, join our free newsletter here.

FREE Stock Screener

Don’t forget to check out our FREE Large Cap 1000 – Stock Screener, here at The Acquirer’s Multiple:


Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.